LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 513 | 10000 | 10362 | 0.9651 | 0.9836 |
MCF 10A | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 513 | 8625 | 10473 | 0.8236 | 0.9126 |
MCF 10A | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 513 | 7518 | 10362 | 0.7254 | 0.8571 |
MCF 10A | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 513 | 5019 | 10473 | 0.4788 | 0.6853 |
MCF 10A | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 513 | 2539 | 10362 | 0.2449 | 0.4440 |
MCF 10A | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 513 | 2001 | 10473 | 0.1911 | 0.3664 |
MCF 10A | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 513 | 593 | 10362 | 0.0572 | 0.0334 |
MCF 10A | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 513 | 778 | 10473 | 0.0743 | 0.0995 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 513 | 348 | 10362 | 0.0336 | -0.0875 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 513 | 459 | 10473 | 0.0438 | -0.0260 |
MCF 10A | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 513 | 283 | 10362 | 0.0273 | -0.1286 |
MCF 10A | GSK1059615 | 10 | uM | LJP6 | 72 | hr | 513 | 317 | 10473 | 0.0302 | -0.1063 |
MCF 10A | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 513 | 9764 | 10362 | 0.9421 | 0.9726 |
MCF 10A | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 513 | 9366 | 10362 | 0.9037 | 0.9537 |
MCF 10A | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 513 | 9301 | 10362 | 0.8976 | 0.9508 |
MCF 10A | Brivanib | 1.11 | uM | LJP5 | 72 | hr | 513 | 7272 | 10362 | 0.7015 | 0.8425 |
MCF 10A | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 513 | 4641 | 10362 | 0.4476 | 0.6600 |
MCF 10A | Brivanib | 10 | uM | LJP5 | 72 | hr | 513 | 1479 | 10362 | 0.1428 | 0.2765 |
MCF 10A | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 513 | 9979 | 10473 | 0.9528 | 0.9776 |
MCF 10A | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 513 | 9570 | 10473 | 0.9138 | 0.9587 |
MCF 10A | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 513 | 8716 | 10473 | 0.8322 | 0.9173 |
MCF 10A | CHIR-99021 | 1.11 | uM | LJP6 | 72 | hr | 513 | 6771 | 10473 | 0.6464 | 0.8082 |
MCF 10A | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 513 | 6115 | 10473 | 0.5838 | 0.7670 |
MCF 10A | CHIR-99021 | 10 | uM | LJP6 | 72 | hr | 513 | 4632 | 10473 | 0.4423 | 0.6542 |
MCF 10A | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 513 | 11575 | 10473 | 1.1054 | 1.0465 |